Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
Become a Member | Sign in
Home>Products>This Product

GreenScreen HC

Product Image
Product Description

GreenScreen® HC is an accurate and fast in vitro human cell-based assay for the assessment of genotoxicity and cytotoxicity of compounds and mixtures.

The assay detects substances that are capable of causing damage to genetic material (DNA) within a cell. GreenScreen HC uses the human-derived, p53 competent, TK6 cell line to host a patented green fluorescent protein (GFP) reporter  system which exploits the proper regulation of the GADD45a gene.

Exposure to a genotoxic compound increases the expression of GADD45a and hence the induction of GFP production in the test strain. Simultaneous quantification of relative cell density or cell viability allows assessment of cytotoxicity.

•    Unique combination of high specificity and high sensitivity for genotoxicity
•    Detects all mechanistic classes of genotoxin (mutagens, aneugens and clastogens)
•    Most accurate genotoxicity screening test available
•    Simple, robust and fast protocol
•    Low sample requirement

The 96-well microplate format takes about 20 minutes to prepare and delivers results after a 48 hour incubation. A single microplate is used for the simultaneous testing of 4 compounds over 9 serial dilutions. The protocol is readily automated using standard laboratory equipment.

Product GreenScreen HC
Company Gentronix Ltd.
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

Gentronix Ltd.
BioHub at Alderley Park Alderley Edge Cheshire SK10 4TG United Kingdom

Tel: +44 (0)1625 238700
Fax: +44 (0)1625 238701

Scientific News
Cell's Waste Disposal System Regulates Body Clock Proteins
New way to identify interacting proteins could identify potential drug targets.
Compound Doubles Up On Cancer Detection
Researchers have found that tagging a pair of markers found almost exclusively on a common brain cancer yields a cancer signal that is both more obvious and more specific to cancer.
Promising Drug Candidate to Treat Chronic Itch
In a new study, scientists from the Florida campus of The Scripps Research Institute (TSRI) describe a class of compounds with the potential to stop chronic itch without the adverse side effects normally associated with medicating the condition.
Are Changes to Current Colorectal Cancer Screening Guidelines Required?
Editorial suggests more research is needed to pinpoint age to end aggressive screening.
Assessing Cancer Patient Survival and Drug Sensitivity
RNA editing events another way to investigate biomarkers and therapy targets.
New Molecular Marker for Killer Cells
Cell marker enables prognosis about the course of infections.
Potential Target for Treatment of Autism
Grant of $2.4 million will support further research.
Sniffing Out Cancer
Scientists have been exploring new ways to “smell” signs of cancer by analyzing what’s in patients’ breath.
Inroads Against Leukaemia
Potential for halting disease in molecule isolated from sea sponges.
Molecular ‘Kiss Of Death’ Flags Pathogens For Destruction
Researchers have discovered that our bodies mark pathogen-containing vacuoles for destruction by using a molecule called ubiquitin, commonly known as the "kiss of death."


Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos